Interventions to increase uptake of Human Papillomavirus (HPV) vaccination in minority populations: A systematic review.

Breanne E Lott, Babasola O Okusanya, Elizabeth J Anderson, Nidal A Kram, Melina Rodriguez, Cynthia A Thomson, Cecilia Rosales, John E Ehiri
Author Information
  1. Breanne E Lott: Department of Health Promotion Sciences, Mel and Enid Zukerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  2. Babasola O Okusanya: Department of Health Promotion Sciences, Mel and Enid Zukerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  3. Elizabeth J Anderson: Department of Health Promotion Sciences, Mel and Enid Zukerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  4. Nidal A Kram: Department of Health Promotion Sciences, Mel and Enid Zukerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  5. Melina Rodriguez: Department of Health Promotion Sciences, Mel and Enid Zukerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  6. Cynthia A Thomson: Canyon Ranch Center for Prevention and Health Promotion, Department of Health Promotion Sciences, Mel and Enid Zukerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  7. Cecilia Rosales: Division of Public Health Practice and Translational Research, Mel and Enid Zukerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  8. John E Ehiri: Department of Health Promotion Sciences, Mel and Enid Zukerman College of Public Health, University of Arizona, Tucson, AZ, USA.

Abstract

Minority youth represent a unique population for public health interventions given the social, economic, and cultural barriers they often face in accessing health services. Interventions to increase uptake of Human Papillomavirus (HPV) vaccination in minority youth have the potential to reduce disparities in HPV infection and HPV-related cancers. This systematic review assesses the effectiveness of interventions to increase HPV vaccine uptake, measured as vaccine series initiation and series completion, among adolescents and young adults, aged 9-26 years old, identifying as a racial and ethnic minority or sexual and gender minority (SGM) group in high-income countries. Of the 3013 citations produced by a systematic search of three electronic databases (PubMed, Embase, and Web of Science) in November 2018, nine studies involving 9749 participants were selected for inclusion. All studies were conducted in the United States and were published from 2015 to 2018. Interventions utilized education, vaccine appointment reminders, and negotiated interviewing to increase vaccination. Participants were Black or African American (44.4%), Asian (33.3%), Hispanic or Latinx (22.2%), American Indian or Alaska Native (11.1%), and SGM (22.2%). Studies enrolled parent-child dyads (33.3%), parents alone (11.1%), and youth alone (55.6%). Vaccine series initiation ranged from 11.1% to 84% and series completion ranged from 5.6% to 74.2% post-intervention. Educational and appointment reminder interventions may improve HPV vaccine series initiation and completion in minority youth in the U.S. Given the lack of high quality, adequately powered studies, further research is warranted to identify effective strategies for improving HPV vaccine uptake for minority populations.

Keywords

References

  1. Vaccine. 2020 Jan 3;38(1):39-45 [PMID: 31611099]
  2. J Adolesc Health. 2010 Dec;47(6):596-9 [PMID: 21094437]
  3. Ann Intern Med. 2009 Aug 18;151(4):264-9, W64 [PMID: 19622511]
  4. Ann Fam Med. 2011 Jan-Feb;9(1):37-43 [PMID: 21242559]
  5. Syst Rev. 2017 Dec 06;6(1):245 [PMID: 29208034]
  6. Pediatrics. 2016 Jul;138(1): [PMID: 27296865]
  7. BMC Public Health. 2018 Jun 15;18(1):746 [PMID: 29907115]
  8. Hum Vaccin Immunother. 2016 Jun 2;12(6):1566-88 [PMID: 26838959]
  9. Vaccine. 2011 May 12;29(21):3767-72 [PMID: 21440038]
  10. Vaccine. 2013 Apr 12;31(16):2028-34 [PMID: 23474310]
  11. J Adolesc Health. 2004 Aug;35(2):160-7 [PMID: 15298005]
  12. Prev Med. 2010 Aug;51(2):182-4 [PMID: 20538014]
  13. Am J Prev Med. 2019 Apr;56(4):591-602 [PMID: 30773231]
  14. J Cancer Educ. 2015 Jun;30(2):353-9 [PMID: 24898942]
  15. MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):918-924 [PMID: 30138307]
  16. Clin Ther. 2014 Jan 1;36(1):24-37 [PMID: 24417783]
  17. Womens Health Issues. 2012 Nov-Dec;22(6):e571-9 [PMID: 23122214]
  18. J Adolesc Health. 2015 Jan;56(1):85-90 [PMID: 25438965]
  19. Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1463-72 [PMID: 21602307]
  20. MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):625-33 [PMID: 25055186]
  21. Hum Vaccin Immunother. 2015;11(12):2883-94 [PMID: 26378650]
  22. J Cancer Educ. 2018 Oct;33(5):1126-1131 [PMID: 28456947]
  23. Vaccine. 2014 Apr 7;32(17):1901-20 [PMID: 24530401]
  24. Pediatrics. 2011 Jan;127(1):77-84 [PMID: 21149425]
  25. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1257-61 [PMID: 16835320]
  26. Vaccine. 2018 Jun 18;36(26):3868-3875 [PMID: 29778516]
  27. Hum Vaccin Immunother. 2014;10(9):2632-5 [PMID: 25483503]
  28. J Community Health. 2016 Apr;41(2):274-81 [PMID: 26399648]
  29. BMJ. 2016 Oct 12;355:i4919 [PMID: 27733354]
  30. J Am Coll Health. 2016 May-Jun;64(4):269-78 [PMID: 26821923]
  31. Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142 [PMID: 31643080]
  32. Public Health. 2017 Mar;144:86-91 [PMID: 28274389]
  33. Public Health. 2017 Jan;142:167-176 [PMID: 27592005]
  34. J Pediatr Adolesc Gynecol. 2015 Feb;28(1):19-23 [PMID: 25444051]
  35. LGBT Health. 2018 Jul;5(5):325-329 [PMID: 29979642]
  36. Clin Pediatr (Phila). 2013 Mar;52(3):231-40 [PMID: 23362316]
  37. J Pediatr. 2010 Oct;157(4):617-22 [PMID: 20472250]
  38. J Cancer Educ. 2019 Feb;34(1):66-72 [PMID: 28808906]
  39. Appl Nurs Res. 2018 Apr;40:51-60 [PMID: 29579499]
  40. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702 [PMID: 31415491]
  41. MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300-4 [PMID: 25811679]
  42. BMJ. 2011 Oct 18;343:d5928 [PMID: 22008217]
  43. Vaccine. 2018 Aug 9;36(33):5065-5070 [PMID: 30037419]
  44. Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941 [PMID: 29342498]
  45. Acta Cytol. 2016;60(6):518-526 [PMID: 27825171]
  46. Clin Pediatr (Phila). 2016 Aug;55(9):851-9 [PMID: 26968631]
  47. Prev Med. 2019 Jun;123:197-203 [PMID: 30930259]

Grants

  1. R25 CA217725/NCI NIH HHS

Word Cloud

Created with Highcharts 10.0.0HPVminorityvaccineseriesyouthincreaseuptakestudiesinterventionsInterventionsPapillomavirusvaccinationsystematicreviewinitiationcompletion2%111%MinoritypopulationhealthHumandisparitiesSGM2018appointmentAmerican333%22alone6%rangedrepresentuniquepublicgivensocialeconomicculturalbarriersoftenfaceaccessingservicespotentialreduceinfectionHPV-relatedcancersassesseseffectivenessmeasuredamongadolescentsyoungadultsaged9-26 yearsoldidentifyingracialethnicsexualgendergrouphigh-incomecountries3013citationsproducedsearchthreeelectronicdatabasesPubMedEmbaseWebScienceNovembernineinvolving9749participantsselectedinclusionconductedUnitedStatespublished2015utilizededucationremindersnegotiatedinterviewingParticipantsBlackAfrican444%AsianHispanicLatinxIndianAlaskaNativeStudiesenrolledparent-childdyadsparents55Vaccine84%574post-interventionEducationalremindermayimproveUSGivenlackhighqualityadequatelypoweredresearchwarrantedidentifyeffectivestrategiesimprovingpopulationspopulations:CancerpreventionHealthInterventionSystematic

Similar Articles

Cited By